| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,445,000 | 2,283,973 | 2,287,659 | 2,373,882 | | Cost of Revenue | 366,000 | 407,458 | 391,271 | 422,151 | | | Gross Profit | 2,079,000 | 1,876,515 | 1,896,388 | 1,951,731 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,058,000 | 1,040,211 | 1,116,631 | 1,165,374 | | Non Recurring |
-
| 6,099,000 | 11,000 | (25,000) | | Others | 425,000 | 1,284,139 | 417,000 | 309,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 596,000 | (6,546,835) | 351,757 | 502,357 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 596,000 | (6,546,835) | 351,757 | 502,357 | | Interest Expense | 204,000 | 249,898 | 255,529 | 228,803 | | Income Before Tax | 392,000 | (6,796,733) | 96,228 | 273,554 | | Income Tax Expense | 315,000 | (578,706) | 5,870 | 66,908 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 77,000 | (6,218,027) | 90,358 | 206,646 | | | Non-recurring Events | | Discontinued Operations |
-
| (269) | (10,897) | (253) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 77,000 | (6,218,296) | 79,461 | 206,393 | | Preferred Stock And Other Adjustments |
-
| (26,236) |
-
|
-
| | | Net Income Applicable To Common Shares | $77,000 | ($6,244,532) | $79,461 | $206,393 |
|
0.45% Nasdaq 
0.20%
Income Statement
